search
for
 About Bioline  All Journals  Testimonials  Membership  News


Neurology India
Medknow Publications on behalf of the Neurological Society of India
ISSN: 0028-3886 EISSN: 1998-4022
Vol. 53, Num. 2, 2005, pp. 243-245

Neurology India, Vol. 53, No. 2, April-June, 2005, pp. 243-245

Letter To Editor

Myasthenia gravis associated with fibrous histiocytoma

Departments of Neurosurgery, Sir Ganga Ram Hospital, New Delhi

Correspondence Address: Departments of Neurosurgery, Sir Ganga Ram Hospital, New Delhi, dr_abhi_agrawal@yahoo.co.in

Date of Acceptance: 04-Apr-2005

Code Number: ni05082

Sir,

Association of myasthenia gravis with extrathymic malignancies, especially leukemia, reticuloendothelial, and solid tissue malignancy, has been described, abeit rarely. [1],[2],[3] In a series of 296 thymectomized myasthenic cases, only 5 patients had extrathymic fibrous histiocytoma and extrathymic malignancies were observed more frequently in thymomatous myasthenia than in nonthymomatous ones.[4]

A 35-year-old male presented with gradually progressive dysphagia for solids for 6-month duration. For the last 1 month, he experienced diplopia especially in extremes of continuous horizontal gaze and occasional jaw weakness. Two weeks prior to hospitalization, he also developed dyspnea. There was no history of a focal or generalized muscular weakness. A 6-cm round, well defined, soft tissue swelling was noted in the left infraclavicular area. There were no other focal neurological deficits. The tensilon test and repetitive nerve stimulation test were suggestive of myasthenia gravis. However, anticholinesterase antibodies were not detected. Antinuclear antibody, RA factor, immunoglobulin levels, and other sero-markers were also negative.

Spiral computerized tomography (CT) scan of the thorax did not reveal any thymic lesion, but an extrathoracic soft tissue mass was observed in the left intraclavicular region [Figure - 1]. A subsequently performed CT-guided fine needle aspiration cytology was suggestive of a spindle cell tumor. He underwent enucleation of the mass and the diagnosis of fibrous histiocytoma was confirmed by CD-68 stains, which were positive for histiocyte cells, while the cytokeratin and epithelial membrane antigens were negative [Figure - 2] and [Figure - 3]. Postoperatively his breathlessness and swallowing difficulty improved. He underwent phasmapheresis along with anticholinestenase and immunomodulation therapy and showed gradual symptomatic improvement.

The prominent clinical feature of this patient was pharyngeal weakness followed by diplopia and breathlessness. It was associated with extrathoracic soft tissue swelling in the left infraclavicular region. History, clinical examination and electrophysiological evaluation suggested postsynaptic neuromuscular junction disorder and the tensilon test was positive. The mass, which turned out to be fibrous histiocytoma, was excised. Other possibilities of such presentation are in cases of oculopharyngeal muscular dystrophy, bulbar palsy, and AIDP inflammatory myopathy, but these were ruled out on the basis of clinical course, investigation and response to medication. oma found to have ththymoms an Autoimmune Disease and approximately 10% of patients with myasthenia

In the literature, 59 myasthenic cases with an extrathymic malignancy were found. There were 18 cases of thymomatous myasthenia and 41 nonthymomatous ones. The primary site of extrathymic malignancy was blood-forming organs, namely, 15 cases of leukemia and sarcoma of reticuloendothelial system, breast (eight), lung (six), thyroid (five), digestive tract (four), skin (three), uterus (three), fibrous histiocytoma (three), miscellaneous (eight), and unknown (five).[4]

Thus, myasthenia gravis although not an uncommon neurological disorder, its association with extrathymic malignancy is very rare and the rarest association is with fibrous histiocytoma, as in our case . Further autoimmune research studies are needed to establish their association and interaction at the molecular level.

REFERENCES

1.Seybold ME. Diagnosis of myasthenia gravis. In Engel AG, ed. Myasthenia gravis and myasthenia disorders. New York: Oxford University press 1999: 146-66.  Back to cited text no. 1    
2.Masaoka A, Yamakawa Y, Niwa H, et al . Thymectomy and malignancy. Eur J Cardiothoracic Surg 1994; 8:251-3.  Back to cited text no. 2    
3.Evoli A, Punzi C, Marsili F, et al . Extrathymic malignancies in patients with thymoma. Ann Oncol. 2004; 15:692-3.  Back to cited text no. 3    
4.Monden Y, Uyama T, Kimura S, et al . Extrathymic malignancy in patients with myasthenia gravis. Eur J Cancer 1991; 27:745-7.  Back to cited text no. 4    

Copyright 2005 - Neurology India


The following images related to this document are available:

Photo images

[ni05082f3.jpg] [ni05082f2.jpg] [ni05082f1.jpg]
Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil